Liver fibrosis: Possible involvement of EMT

被引:50
作者
Ikegami, Tadashi [1 ]
Zhang, Yining
Matsuzaki, Yasushi
机构
[1] Tokyo Med Univ, Div Gastroenterol & Hepatol, Kasumigaura Hosp, Ibaraki 3000395, Japan
[2] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan
关键词
hepatic fibrosis; epithelial-mesenchymal transition; hepatocellular carcinoma; hepatic stellate cell; portal myofibroblast; integrin-linked kinase;
D O I
10.1159/000101322
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Hepatic fibrosis is a wound-healing process in the liver with acute and chronic injury and is characterized by an excess production and deposition of extracellular matrix components. Hepatic stellate cells as well as portal fibroblasts play a pivotal role in the liver fibrogenesis. Regarding the origin of these mesenchymal cells, two hypotheses emerge. One hypothesis argues in favor of BM-derived progenitor cells and a second hypothesis favors epithelial-mesenchymal transition (EMT) in the local formation of these mesenchymal cells from hepatic epithelium. In this short review, we describe (1) the principle mechanisms of hepatic fibrosis, (2) the cells which play a crucial role in hepatic fibrosis, and (3) the possible involvement of EMT in the process of hepatic fibrosis and carcinogenesis. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:213 / 221
页数:9
相关论文
共 61 条
[1]   Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C [J].
Arthur, MJP .
GASTROENTEROLOGY, 2002, 122 (05) :1525-1528
[2]   Hepatic stellate cells as a target for the treatment of liver fibrosis [J].
Bataller, R ;
Brenner, DA .
SEMINARS IN LIVER DISEASE, 2001, 21 (03) :437-451
[3]   The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression [J].
Cano, A ;
Pérez-Moreno, MA ;
Rodrigo, I ;
Locascio, A ;
Blanco, MJ ;
del Barrio, MG ;
Portillo, F ;
Nieto, MA .
NATURE CELL BIOLOGY, 2000, 2 (02) :76-83
[4]   Synaptophysin: A novel marker for human and rat hepatic stellate cells [J].
Cassiman, D ;
van Pelt, J ;
De Vos, R ;
Van Lommel, F ;
Desmet, V ;
Yap, SH ;
Roskams, T .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) :1831-1839
[5]   Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers [J].
Cassiman, D ;
Libbrecht, L ;
Desmet, V ;
Denef, C ;
Roskams, T .
JOURNAL OF HEPATOLOGY, 2002, 36 (02) :200-209
[6]   Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis [J].
Czaja, AJ ;
Carpenter, HA .
JOURNAL OF HEPATOLOGY, 2004, 40 (04) :646-652
[7]   Integrin-linked kinase (ILK): a regulator of integrin and growth-factor signalling [J].
Dedhar, S ;
Williams, B ;
Hannigan, G .
TRENDS IN CELL BIOLOGY, 1999, 9 (08) :319-323
[8]   The stroma reaction myofibroblast:: a key player in the control of tumor cell behavior [J].
Desmoulière, A ;
Guyot, C ;
Gabbiani, C .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2004, 48 (5-6) :509-517
[9]   Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss [J].
Dixon, JB ;
Bhathal, PS ;
Hughes, NR ;
O'Brien, PE .
HEPATOLOGY, 2004, 39 (06) :1647-1654
[10]   Reversibility of hepatic fibrosis in autoimmune hepatitis [J].
Dufour, JF ;
DeLellis, R ;
Kaplan, MM .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (11) :981-985